ArticleClinical and translational science2020

Evaluating Potential Disease-Mediated Protein-Drug Interactions in Patients With Moderate-to-Severe Plaque Psoriasis Receiving Subcutaneous Guselkumab.

Yaowei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.